Capital International Inc’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
HA
SCM
DM
B
Capital International Inc's LEGN Position: Q3 2025 in Review
Capital International Inc sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 157,896 shares — an estimated $5.6M sold.
Capital International Inc first reported a position in LEGN in Q2 2020 and held it in 21 quarters. The position peaked at $97.1M in Q3 2021. 199 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.
- Capital International Inc reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
- Capital International Inc sold 157,896 Legend Biotech shares in Q3 2025, an estimated $5.6M.
- Capital International Inc first reported a position in Legend Biotech in Q2 2020 and held it in 21 quarters.
- Capital International Inc's Legend Biotech position peaked at $97.1M in Q3 2021.
- 199 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.
Based on Capital International Inc's 13F filing for Q3 2025, filed 13 Nov 2025.